Page last updated: 2024-08-24

triazoles and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

triazoles has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajjala, DR; Aleti, R; Kandikere, V; Nirogi, R; Srikakolapu, S; Vurimindi, H1

Other Studies

1 other study(ies) available for triazoles and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Dried blood spot analysis of an iron chelator--deferasirox and its potential application to therapeutic drug monitoring.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012, Oct-15, Volume: 907

    Topics: Administration, Intravenous; Administration, Oral; Animals; Benzoates; Chromatography, Liquid; Deferasirox; Dried Blood Spot Testing; Drug Monitoring; Drug Stability; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Iron Chelating Agents; Linear Models; Male; Rats; Rats, Wistar; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles

2012